Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Cited by (924)

Items 201–300 of 924

1. Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population
   Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela‐Nogueira, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Mateus Jorge Nardelli, Luciana Costa Faria, Nathália Mota de Faria Gomes, Elze Maria Gomes Oliveira et al. · 2021 · Annals of Hepatology
2. Cholestatic pruritus: a knowledge update
   Thaís Reginatto Nietsche, Gabriel Dotta, Carlos Baptista Barcauí, Maria Lúcia Gomes Ferraz · 2022 · Anais Brasileiros de Dermatologia
3. Interferon-induced protein with tetratricopeptide repeats 3 may be a key factor in primary biliary cholangitis
   Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2021 · Scientific Reports
4. Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?
   Xin Luo, Lungen Lu · 2024 · Journal of Clinical and Translational Hepatology
5. Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis
   Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela‐Nogueira, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Mateus Jorge Nardelli, Luciana Costa Faria, Nathália Mota de Faria Gomes, Elze Maria Gomes Oliveira et al. · 2021 · Digestive Diseases and Sciences
6. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
   Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim M. Qumosani, Mark G. Swain, Dusanka Grbic, Hin Hin Ko et al. · 2024 · JHEP Reports
7. Post-Transplant Immunosuppression in Autoimmune Liver Disease
   Claire Kelly, Yoh Zen, Michael A. Heneghan · 2022 · Journal of Clinical and Experimental Hepatology
8. Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study
   Helen T. Smith, Sugato Das, James Fettiplace, Robyn von Maltzahn, Philip J.F. Troke, Megan McLaughlin, David E. Jones, Andreas Emanuel Kremer · 2025 · Hepatology Communications
9. Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis
   Harms, Maren H., Hirschfield, Gideon M., Floreani, Annarosa, Mayo, Marlyn J., Parés, Albert, Liberman, Alexander, Malecha, Elizabeth Smoot, Pencek, Richard, MacConell, Leigh, Hansen, Bettina E. · 2021 · JHEP Reports
10. Fenofibrate improves GLOBE and UK-PBC scores and histological features in primary biliary cholangitis
    Lu Wang, Keshuai Sun, Ai TIAN, Yansheng LIU, Miao Zhang, Xinmin Zhou, Ying Han · 2022 · Minerva Medica
11. Dihydropyridopyrazine Functionalized Xanthene: Generating Stable NIR Dyes with Small‐Molecular Weight by Enhanced Charge Separation
    Xingxing Zhang, Feiyu Yang, Xinyu Zhao, Qian Wu, Long He, Zhe Li, Zhixuan Zhou, Tian‐Bing Ren, Xiaobing Zhang, Lin Yuan · 2024 · Angewandte Chemie International Edition
12. A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers
    Cynthia Levy, Keri-Ann Buchanan-Peart, Joanna P. MacEwan, Alina Levine, Radhika Nair, Darren Wheeler, Leona Bessonova, Aparna Goel, Robert Gareth Gish, Alan Bonder · 2025 · Hepatology Communications
13. Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase
    Da-Wei Ding, Guo-Yun Xuan, Yi-Nan Hu, Jia-Hao Yu, Yan-Sheng Liu, Guan-Ya Guo, Shuo-Yi Ma, Fang-Fang Yang, Si-Yuan Tian, Gang Ma et al. · 2022 · Hepatology Communications
14. Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients
    Dantong Zhao, Huiping Yan, Ying Han, Wei-Ming Zhang, Yan Zhao, Hui-Yu Liao · 2023 · Frontiers in Endocrinology
15. Distinct EpCAM-Positive Stem Cell Niches Are Engaged in Chronic and Neoplastic Liver Diseases
    Samira Safarikia, Guido Carpino, Diletta Overi, Vincenzo Cardinale, Rosanna Venere, Antonio Franchitto, Paolo Onori, Domenico Alvaro, Eugenio Gaudio · 2020 · Frontiers in Medicine
16. Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis
    Yichen Han, Zhen-Hua Bian, Si-Yu Yang, Chengbo Wang, Liang Li, Yanqing Yang, Aftab Ahmed Ansari, Merrill Eric Gershwin, Xiaofeng Zeng, Zhe‐Xiong Lian et al. · 2022 · Frontiers in Immunology
17. Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases
    Ellina Lytvyak, Gideon Morris Hirschfield, Devika Shreekumar, Yu Jun Wong, Aldo J. Montaño‐Loza · 2025 · Liver International
18. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER
    Cláudia Alves Couto, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Gilda Porta, Cynthia Levy, Antônio Eduardo Benedito Silva, Paulo Lisboa Bittencourt, Roberto José de Carvalho‐Filho, Dalton Marques CHAVES, Irene Kazue Miura et al. · 2019 · Arquivos de Gastroenterologia
19. Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria
    Dawei Ding, Guanya Guo, Lina Cui, Gui Jia, Xiufang Wang, Miao Zhang, Siyuan Tian, Linhua Zheng, Yansheng Liu, Yinan Hu et al. · 2023 · Hepatology International
20. The use of biologics in the treatment of autoimmune liver disease
    Christopher Chia-Chi Chang, Atsushi Tanaka, Christopher L. Bowlus, Merrill Eric Gershwin · 2020 · Expert Opinion on Investigational Drugs
21. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy
    Ampuero, Javier, Lucena, Ana, Berenguer, Marina, Hernández-Guerra, Manuel, Molina, Esther, Gómez-Camarero, Judith, Valdivia, Carlos, Gómez, Elena, Casado, Marta, Álvarez-Navascuez, Carmen et al. · 2024 · Hepatology
22. Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis
    Chenyi Xu, Rensong Yue, Xuelian Lv, Shengnan Wang, Mengmeng Du · 2022 · Frontiers in Pharmacology
23. The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
    Kazuhito Kawata, Satoru Joshita, Shinji Shimoda, Yūki Yamashita, M. Yamashita, Kensuke Kitsugi, Shingo Takatori, Kazuyoshi Ohta, Jun Ito, Shin Shimoyama et al. · 2020 · Hepatology Research
24. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial
    Robyn von Maltzahn, Marlyn J. Mayo, Helen T. Smith, April H. Thompson, Sugato Das, Andréa Ribeiro de Souza, Edoardo Lisi, Cynthia Levy, Megan McLaughlin, David E. Jones · 2024 · Journal of Patient-Reported Outcomes
25. Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility
    Zsuzsanna Hortobagyi McMahan, Srinivas N. Puttapaka, Livia A Casciola-Rosen · 2025 · Annals of the Rheumatic Diseases
26. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review
    Sheena Mago, George Y. Wu · 2020 · Journal of Clinical and Translational Hepatology
27. Primary biliary cholangitis and the narrowing gap towards optimal disease control
    Guilherme Grossi Lopes Cançado, Ana Lleò, Cynthia Levy, Michael Trauner, Gideon Morris Hirschfield · 2025 · The Lancet. Gastroenterology & hepatology
28. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
    Rosanna Villani, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, Emanuele D’Amico · 2023 · Clinical and Experimental Medicine
29. Levels of serum IgG subclasses in patients with liver disease: A retrospective study
    Wei Zheng, Feifei Jiang, Jing Shan, Ying Wang, Yongmei Jia, Qiuyan Guo, Jinli Lou, Yan Zhao · 2020 · Experimental and Therapeutic Medicine
30. Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy
    Umberto Vespasiani Gentilucci, Floriano Rosina, Valeria Pace-Palitti, Rodolfo Sacco, Adriano Maria Pellicelli, Luchino Chessa, Antonio De Vincentis, Michela Barlattani, Angelo Barlattani, Valentina Feletti et al. · 2019 · Scandinavian Journal of Gastroenterology
31. Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)
    V. F. Trevisani, A. Pinheiro, S. C. de Magalhães Souza Fialho, M. Fernandes, A. Pugliesi, S. Pasoto, M. L. Lopes, L. Guedes, S. Miyamoto, Laura Caldas dos Santos et al. · 2022 · Advances in Rheumatology
32. Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis
    Siyuan Tian, Yinan Hu, Miao Zhang, Kemei Wang, Guanya Guo, Bo Li, Yulong Shang, Ying Han · 2023 · Arthritis Research & Therapy
33. Pharmacokinetics and ADME Characterization of Intravenous and Oral [14C]-Linerixibat in Healthy Male Volunteers
    M. Zamek-Gliszczynski, David Kenworthy, David A. Bershas, M. Sanghvi, Adrian I. Pereira, Jennypher Mudunuru, Lee Crossman, Jill L. Pirhalla, Karl M. Thorpe, Jeremy M. T. J. Dennison et al. · 2021 · Drug Metabolism And Disposition
34. Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study
    Masamichi Kimura, Eiichi Ogawa, Kenichi Harada, Jun Imamura, Masanao Saio, Yoshihiro Ikura, Hiroshi Yatsuhashi, Kazumoto Murata, Kouichi Miura, Ichiro Ieiri et al. · 2022 · BMJ Open Gastroenterology
35. Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
    Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Laura Vilar Guedes, Michelle Harriz Braga, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela‐Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria et al. · 2022 · Frontiers in Pharmacology
36. Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
    Hye-Jung Jang, Nayoung Han, Christine E. Staatz, Jae‐Hwan Kwak, In‐hwan Baek · 2023 · Clinics and Research in Hepatology and Gastroenterology
37. Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
    Soon Kyu Lee, Soon Kyu Lee, Jung Hyun Kwon · 2022 · Journal of Hepatology
38. Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis
    Esli Medina‐Morales, Romelia Barba, Heike Gerger, Daniela Goyes, Hirsh D. Trivedi, Bryan W. Ferrigno, Vilas R. Patwardhan, Alan Bonder · 2022 · Journal of Clinical Gastroenterology
39. Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis
    Haifu Zhang, Shuojun Li, Yong-Hang Feng, Qinxia Zhang, Biyun Xie · 2022 · Clinical and Experimental Medicine
40. Possible application of melatonin treatment in human diseases of the biliary tract
    Leonardo Baiocchi, Tianhao Zhou, Suthat Liangpunsakul, Ilaria Lenci, Martina Milana, Fanyin Meng, Lindsey Leann Kennedy, Praveen Kusumanchi, Zhihong Yang, Ludovica Ceci et al. · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
41. Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases
    Punnag Saha, Phillipp Hartmann · 2025 · Microorganisms
42. Current and promising therapy for primary biliary cholangitis
    Andrea A. Gossard, Keith D. Lindor · 2019 · Expert Opinion on Pharmacotherapy
43. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
    Marco Carbone, Alessio Gerussi, Vincenzo Cardinale, Nora Cazzagon, Valentina Cossiga, Ana Lleò, Giuseppe Marrone, Marco Marzioni, Antonio Moschetta, Luca Muratori et al. · 2024 · Digestive and Liver Disease
44. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia
    Eastern Slovakia PBC Group, Sylvia Dražilová, Ingrid Babinská, Jakub Gazda, Monika Halánová, Martin Janíčko, Branislav Kucinsky, Dominik Šafčák, Dominika Martinkova, Lucia Tarbajova et al. · 2020 · International Journal of Public Health
45. Low screening rates and high prevalence of osteoporosis in cirrhosis: A real‐world retrospective analysis
    Mary Thomson, Adam W. Scott, Suzanne Trost, Jack Lake, Nicholas Lim · 2023 · Alimentary Pharmacology & Therapeutics
46. Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis
    Rui Wang, Qiuxiang Lin, Zhonghua Lu, Haoyu Wen, Fangqin Hu, Jia You, Yonghong He, Yuan Fang, Zhaolian Bian, Qiuchen Hou et al. · 2024 · Journal of Autoimmunity
47. Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis
    Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Cristiane Alves Villela‐Nogueira, Maria Lúcia Gomes Ferraz, Michelle Harriz Braga, Mateus Jorge Nardelli, Luciana Costa Faria, Nathália Mota de Faria Gomes et al. · 2022 · Digestive Diseases and Sciences
48. Secondary bile acids and the biliary epithelia: The good and the bad
    Ilaria Lenci, Martina Milana, Alessandro Signorello, Giuseppe B. Grassi, Leonardo Baiocchi · 2023 · World Journal of Gastroenterology
49. Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis
    Sha Chen, Mengqi Li, Weijia Duan, Bu Er Li, Shuxiang Li, Ting-Ting Lv, Lin Ma, Jidong Jia · 2022 · Hepatobiliary & pancreatic diseases international
50. Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
    Guoyun, Xuan, Dawei, Ding, Ning, Liu, Yinan, Hu, Fangfang, Yang, Siyuan, Tian, Hao, Sun, Jiaqi, Yang, Ang, Xu, Guanya, Guo et al. · 2022 · Frontiers in Pharmacology
51. Primary Biliary Cholangitis: A Brief Overview
    Justin S. Louie, Sirisha Grandhe, Karen E. Matsukuma, Christopher L. Bowlus · 2020 · Clinical Liver Disease
52. Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis of Randomized Controlled Trials
    Behrad Saeedian, Nastaran Babajani, Tannaz Bagheri, Fatemeh Ojaghi Shirmard, Seyed Morteza Pourfaraji · 2025 · BMC Gastroenterology
53. Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy
    Ritika Tewari, Soo Jung Yang, Ethan D. McClain, Alex K. Hu, Emma Mortensen, Aleah M DeSchmidt, Janice Chen, Aravind Kancharla, Akhilesh K. Singh, Eddie A. James et al. · 2024 · Journal of Autoimmunity
54. Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis
    Sha Chen, Tingting Lv, Guangyong Sun, Shuxiang Li, Weijia Duan, Chunpan Zhang, Hua Jin, Dan Tian, Mingyang Li, Shan Shan et al. · 2022 · Hepatology International
55. Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis
    Alicja Bauer, Andrzej Habior, Paulina Wieszczy, Damian Gaweł · 2021 · Diagnostics
56. Understanding fatigue and pruritus in primary biliary cholangitis
    Asma Faisal · 2024 · Clinical Liver Disease
57. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis
    Elísabet Poyatos-Canton, Francisco Morandeira, Joan Climent, Virgínia Mas, José Castellote, Jordi Bas · 2021 · Clinical Immunology
58. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis
    Alicja Bauer, Andrzej Habior, Damian Gaweł · 2022 · Biomedicines
59. Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis
    Emanuel K. Manesis, Maria Schina, Irene Vafiadis, Ilias Gatos, John Theotokas, Pavlos Spyridon Zoumpoulis, Peter Drazinos, John Ketikoglou, Ioanna Kassiani Delladetsima, DINA G. TINIAKOS · 2021 · Scandinavian Journal of Gastroenterology
60. The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models
    Zilong Wang, Zhicheng Liu, Jiarui Zheng, Lin-Xiang Huang, Rui Jin, Xiaoxiao Wang, Dongbo Chen, Yandi Xie, Bo Feng · 2024 · BMC Gastroenterology
61. The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system
    Dawei Ding, Gui Jia, Lina Cui, Yansheng Liu, Xiufang Wang, Ruiqing Sun, Juan Deng, Guanya Guo, Yulong Shang, Ying Han · 2025 · Digestive and Liver Disease
62. Pregnancy in Chronic Liver Disease: Before and After Transplantation
    Amr Dokmak, Hirsh D. Trivedi, Alan Bonder, Jacqueline Wolf · 2021 · Annals of Hepatology
63. CT and MR imaging of primary biliary cholangitis: a pictorial review
    Yun Zhang, Tianying Zheng, Zixing Huang, Bin Song · 2023 · Insights into Imaging
64. Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk
    Yan Liang, Jie Li, Zhiyu Zhang, Tingwang Jiang, Zaixing Yang · 2024 · Clinics and Research in Hepatology and Gastroenterology
65. Dyslipidemia, Cholangitis and Fatty Liver Disease: The Close Underexplored Relationship: A Narrative Review
    Salvatore Greco, Michele Campigotto, Andrea D’Amuri, Nicolò Fabbri, Angelina Passaro · 2024 · Journal of Clinical Medicine
66. Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
    Zeineb Ben Lamine, Ilhem Ben Jazia, Mariem Ben Ahmed, Ayda Ben Slama, Azza Baccouche, Foued Slama, Ali Jemaa, Ibtissem Ghédira, Amani Mankaï · 2021 · Arab Journal of Gastroenterology
67. Arachidonic acid enhances hepatocyte bile acid uptake and alleviates cholestatic liver disease by upregulating OATP1 expression
    Yanlu Ma, Chen Zou, Yilan Yang, Miao Fang, Yun‐Feng Guan, Jianqi Sun, Yueqiu Gao, Zhi Shang, Xin Zhang · 2024 · Food & Function
68. Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis
    Xinyu Xiang, Yang Xiao-li, Mengyi Shen, Chen Huang, Yifeng Liu, Xiaoli Fan, Li Yang · 2021 · Canadian Journal of Gastroenterology and Hepatology
69. The Causal Effects of Primary Biliary Cholangitis on Thyroid Dysfunction: A Two-Sample Mendelian Randomization Study
    Peng Huang, Yuqing Hou, Yixin Zou, Xiangyu Ye, Rongbin Yu, Sheng Yang · 2021 · Frontiers in Genetics
70. Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients
    Xinyan Zhao, Yan Wang, Rongtao Lai, Xiaojin Wang, Yuecheng Yu, Min� Li, Hong Zhao, Zikun Ma, Mengqi Li, Tiantian Guo et al. · 2024 · Hepatology Communications
71. Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
    Yanlei Yang, Robert Chunhua Zhao, Fengchun Zhang · 2022 · Frontiers in Cell and Developmental Biology
72. Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
    Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou · 2023 · Annals of Hepatology
73. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study
    Jiaqi Yang, Gang Ma, Kemei Wang, Hui Yang, Shuangshuang Jiang, Qingling Fan, Xinmin Zhou, Guanya Guo, Ying Han · 2024 · Frontiers in Medicine
74. Primary Biliary Cholangitis
    Muhammad Salman Faisal, Humberto C. González, Stuart C. Gordon · 2023 · Clinics in Liver Disease
75. Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat
    Eleni Karatza, Brandon Swift, Fernando Carreño, Sumanta Mukherjee, Linda Casillas, Janelle L. Lennie, James Fettiplace, Megan McLaughlin, Andreas Emanuel Kremer · 2024 · Liver International
76. Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis
    Jiaqi Yang, Shuangshuang Jiang, Qingling Fan, Didi Wen, Yansheng Liu, Kemei Wang, Hui Yang, Changcun Guo, Xinmin Zhou, Guanya Guo et al. · 2024 · Frontiers in Medicine
77. Ursodeoxycholic acid loaded dual-modified graphene oxide nanocomposite alleviates cholestatic liver injury through inhibiting hepatocyte apoptosis
    Wanyi Zhou, Xinrui Yang, Yaru Yin, Si Chen, Luxun Yang, Tao Li, Jing Liu, Binghui Lu, Zhangyou Yang, Rong Li et al. · 2024 · Colloids and Surfaces B Biointerfaces
78. Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study
    Rebecca Heijke, Awais Ahmad, Martina Frodlund, Lina Wirestam, Örjan Dahlström, Charlotte Dahle, Stergios Kechagias, Christopher Sjöwall · 2021 · Journal of Clinical Medicine
79. Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis
    Pimsiri Sripongpun, Ananya Pongpaibul, Phunchai Charatcharoenwitthaya · 2021 · BMJ Open Gastroenterology
80. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis
    Yujin Zhu, Jing Li, Yonggang Liu, Yong Jiang, Xiaojing Cheng, Xu Han, Chun-Yan Wang, Jia Li · 2023 · World Journal of Gastroenterology
81. Population Dose–Response‐Time Analysis of Itch Reduction and Patient‐Reported Tolerability Supports Phase III Dose Selection for Linerixibat
    Fernando Carreño, Eleni Karatza, Rashmi S. Mehta, Jon W. Collins, Daren J. Austin, Brandon Swift · 2023 · Clinical Pharmacology & Therapeutics
82. Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China
    Dantong Zhao, Huiping Yan, Hui-Yu Liao, Yanmin Liu, Ying Han, Haiping Zhang, Wei-Ming Zhang, Chunyang Huang, Xiuhong Liu, Jin-Li Lou et al. · 2023 · Frontiers in Immunology
83. The impact of primary biliary cholangitis on non-alcoholic fatty liver disease
    Daniel Iluz‐Freundlich, Julia Uhanova, Micah Grubert Van Iderstine, Gerald Yosel Minuk · 2020 · European Journal of Gastroenterology & Hepatology
84. The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China.
    Qingling Chen, Rui Zhong, Kaihui Dong, Yaoping Wang, Y. Kui, Bo-seif Ma., X. Wen, Q. Jin · 2021 · Digestive and Liver Disease
85. Identification of clinical risk factors for histological progression of primary biliary cholangitis
    Yukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Hideto Kawaratani, Naotaka Shimozato, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Kenichiro Seki et al. · 2019 · Hepatology Research
86. Sleep disturbances in chronic liver disease
    Bradley T. Busebee, Kymberly D. S. Watt, Kara L. Dupuy-McCauley, Hilary M. DuBrock · 2024 · Liver Transplantation
87. Primary biliary cholangitis in pregnancy: A systematic review with meta-analysis
    Hydar El Jamaly, Guy D. Eslick, Martin Weltman · 2022 · Hepatobiliary & pancreatic diseases international
88. Non-Invasive Serum Biomarkers for the Diagnosis of Cirrhosis in Patients with Autoimmune Hepatitis (AIH) and AIH-Primary Biliary Cholangitis Overlap Syndrome (AIH-PBC): Red Cell Distribution Width to Platelet Ratio (RPR) Yielded the Most Promising Result
    Siwanon Nawalerspanya, Jarukit Tantipisit, Suraphon Assawasuwannakit, Apichat Kaewdech, Naichaya Chamroonkul, Pimsiri Sripongpun · 2024 · Diagnostics
89. Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
    Jong-In Chang, Jung Hee Kim, Dong Hyun Sinn, Ju‐Yeon Cho, Kwang Min Kim, Joo Hyun Oh, Yewan Park, Won Sohn, Myung Ji Goh, Wonseok Kang et al. · 2023 · Gut and Liver
90. Longitudinal Relationship Between Elevated Liver Biochemical Tests and Negative Clinical Outcomes in Primary Biliary Cholangitis: A Population‐Based Study
    Kris V. Kowdley, David W. Victor, Joanna P. MacEwan, Radhika Nair, Alina Levine, Jennifer Hernandez, Leona Bessonova, Jing Li, Darren Wheeler, Gideon Morris Hirschfield · 2025 · Alimentary Pharmacology & Therapeutics
91. Update on Emerging Treatment Options for Primary Biliary Cholangitis
    Maria T. Aguilar, David M. H. Chascsa · 2020 · Hepatic Medicine Evidence and Research
92. Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis
    Luis Antonio Manzo-Francisco, Jorge Eduardo Aquino-Matus, Dèsirée Vidaña‐Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia · 2023 · Annals of Hepatology
93. Systemic Complications of Primary Biliary Cholangitis
    Mariana Zapata, Hendrick Pagán-Torres, Marlyn J. Mayo · 2023 · Clinics in Liver Disease
94. Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate
    Yi-Fan Hu, Shun-xin Li, Hong-Li Liu, Zhi-Xiang Du, Shuang-Shuang Wang, Miao‐Yang Chen, Li Wang, Qing‐Fang Xiong, Yan-Dan Zhong, Du-Xian Liu et al. · 2024 · Gut and Liver
95. Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2
    Seyed Reza Hosseini‐Fard, Ahmad Reza Dehpour, Solaleh Emamgholipour, Abolfazl Golestani · 2022 · Life Sciences
96. Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis
    Karn Wijarnpreecha, Monia Elisa Werlang, Panadeekarn Panjawatanan, Surakit Pungpapong, Frank J. Lukens, Denise M. Harnois, Patompong Ungprasert · 2021 · The Indian Journal of Medical Research
97. Characterisation and Clinical Relevance of Tertiary Lymphoid Structures in Primary Biliary Cholangitis
    Hongyu Chu, Yanni Li, Hui Yang, Yuhang Liu, Rongrong Zheng, Xue Zhang, Xiaoyi Wang, Jingwen Zhao, Yujie Zhang, Quan Wang et al. · 2024 · Liver International
98. Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta‐Analysis
    Yuan Gao, Li Li, Bei Li, Yutao Zhan · 2021 · Canadian Journal of Gastroenterology and Hepatology
99. Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical Trial
    Yoshio Sakai, Shinya Fukunishi, Masayuki Takamura et al. · 2020 · JMIR Research Protocols
100. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study
     Rozanne C. de Veer, Maria C. van Hooff, Ellen Werner, Ulrich H. Beuers, Joost P.H. Drenth, Frans J.C. Cuperus, Bart van Hoek, Bart J. Veldt, Michael Klemt‐Kropp, Suzanne van Meer et al. · 2024 · JHEP Reports